SILVA, J. Y. P.; http://lattes.cnpq.br/8522558900388320; SILVA, Jaielison Yandro Pereira da.
Abstract:
Macaíba, Acrocomia instumescens Drude, is a palm tree with an edible almond, characterized by high amounts of saturated fatty acid, essential amino acids and total phenolic compounds. However, it is not very explored and there is scarce data in the scientific literature for its effects on human and animal body, healthy or sick. Thus, the objective of our study was to evaluate the effects of macaíba nut supplementation on murine and biochemical parameters of dyslipidemic adult Wistar rats. The animals were divided into 4 groups: CG (Control Group) (n = 10), CDG (Control Group Dyslipidemic) (n = 9), AG (Almond Group) (n = 9) and ADG Dyslipidemic Almond) (n = 10). The research was fulfilled in two stages, the first phase was the period of induction of dyslipidemia (14 days), through the administration of a high fat emulsion by gavage and the second stage corresponding to the period of 28 days of administration of macaíba almond via gavage. Weight and food intake were evaluated weekly. At the end of the experiment, the animals were anaesthetized and euthanized, and the murine and biochemical evaluations were performed. The results were submitted to one-way analysis of variance, with the Tukey test being applied, being considered a significant difference when p <0.05. Based on the data obtained, it was verified that the almond promoted the weight gain, in addition to the increase in food intake, which had an effect on the increase of the circumferences and the visceral fat, in addition, it caused alterations in the lipid profile, being a predictor for atherosclerotic complications; Influenced liver weight as well as its fat content, as well as increased kidney and creatinine and urea levels. In this way, we can conclude that macaíba almond should not be consumed a long term by individuals with dyslipidemia, as well as by healthy sedentary individuals, as it causes undesirable changes in plasma lipid levels.
